SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                      the Securities Exchange Act of 1934

                        Date of Report: January 12, 2006
                       (Date of earliest event reported)

                               VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)


    Delaware                      0-18105                   11-2871434
(State or other                 (Commission               (IRS Employer
 jurisdiction of                File Number)              Identification
 incorporation)                                              Number)

180 Linden Avenue, Westbury, New York                          11590 
  (Address of principal executive offices)                   (Zip Code)



Registrant's telephone number including area code           (516) 997-4600


                                 Not applicable
         (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[  ] Written communications pursuant to Rule 425 under the Securities Act 
     (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act 
     (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the 
     Exchange Act (17 CFR 240.14d-2(b)

[  ] Pre-commencement communications pursuant to Rule 13e-4c under the 
     Exchange Act (17 CFR 240.13e-4c)



Item 5.02  Departure of Directors or Principal Officers; Election of Directors;
           Appointment of Principal Officers.

        
       (b) Effective January 12, 2006,  Forrest R. Whittaker resigned as a 
           director of Registrant. 


                                   SIGNATURES

     Pursuant to the  requirements  of the  Securities  Exchange Act of 1934, as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                     VASOMEDICAL, INC.
                               
                                     
                                     By:  /s/ Thomas Glover  
                                          Thomas Glover
                                          President and Chief Executive Officer


Dated:   January 17, 2006